Educational resources further distinguish trustworthy suppliers from unreliable sources
Many studies suggest that activation of NRF2 may be able to protect against these conditions (4)
doi: 10.1097/00000542-200312000-00026
Sermorelin was removed from the FDAs 503A compounding list in late 2023, meaning traditional compounded sermorelin is no longer legally available through that pathway
I break down the common symptoms I hear about most (fatigue, brain fog, pain, neurological issues), related conditions (autoimmune disease, chronic fatigue, implant-associated cancers), and the biology behind it: siloxane (silicone) leaching, how bacterial biofilms or mold can play a role, and how the fibrous capsule surrounding implants can trap toxins and sometimes become the site of serious cancers